View allAll Photos Tagged FDA
Agriculture Secretary Sonny Perdue delivers opening remarks at the USDA/FDA Joint Public Meeting on The Use of Cell Culture Technology to Develop Products Derived from Livestock and Poultry at the USDA, Jefferson Auditorium on October 23, 2018. USDA photo by Tom Witham
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
I've been so lucky to win her at the PFDF. She is Fashion Doll Agency doll. They create stylish and elegant fashion dolls. She is a perfect model, very beautiful and gracefully poseable. I love her so much!! It's a pleasure to play with her! She reminds me Kate Moss, so I named her Kate. ^__-
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
FDA’s Howard Sklamberg, Deputy Commissioner for Global Regulatory Operations & Policy, and Cynthia Schnedar, Director, Office of Compliance at CDER, and other FDA officials met with Indian officials in India.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
In recognition of attendance and participation in training courses on FDA - cGMPs Held in February 2010 at Square Pharmaceuticals Limited, Kaliakoir, Gazipur, Bangladesh
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
On March 5, 2018, FDA Commissioner Scott Gottlieb, Senator Michael Burgess, and others toured the International Mail Facility in New York. There they saw firsthand the massive volume of imports that are reviewed daily. More than 340 million packages are sent to the U.S. every year through the International Mail Facilities. FDA staff at these facilities play a critical role in helping ensure they don’t contain counterfeit, unapproved or dangerous products.
FDA recently tripled the number of staff at the International Mail Facilities to improve our ability to inspect packages that are suspected of having drugs. This front-line work is critical to FDA’s ability to protect the public health, but more work remains. The FDA is seeking certain administrative steps to expand the strength of our regulatory oversight and may seek some additional, limited resources and authorities from Congress. FDA is also working closely with our partners at CBP and USPS as part of a new working group.
These photos are free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Privacy and Use Information:
www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth